The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension

被引：0
|
作者：
Samantha L. Wronski
Margaret Mordin
Kim Kelley
Rebekah H. Anguiano
Peter Classi
Eric Shen
Scott Manaker
机构：
[1] RTI Health Solutions,Department of Pharmacy Practice
[2] RTI Health Solutions,Department of Medicine
[3] Rx Trusted Advisors,undefined
[4] University of Illinois at Chicago,undefined
[5] United Therapeutics,undefined
[6] Perelman School of Medicine at the University of Pennsylvania,undefined
来源：
Lung | 2020年 / 198卷
关键词：
PAH; Noninvasive endpoint; Risk assessment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：65 / 86
页数：21
相关论文
共 50 条
  • [31] Predictors of Long-Term Outcomes in Systemic Sclerosis Associated Pulmonary Arterial Hypertension from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry
    Kolstad, Kathleen
    Li, Shufeng
    Steen, Virginai D.
    Chung, Lorinda
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [32] Predictors of Long-term Outcomes in Patients With Connective Tissue Disease Associated With Pulmonary Arterial Hypertension
    Nakayama, Kazuhiko
    Nakajima, Yasuo
    Tanaka, Rika
    Hirata, Ken-ichi
    Emoto, Noriaki
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 (08) : E371 - E377
  • [33] Long-term outcomes of pulmonary arterial hypertension under specific drug therapy in Eisenmenger syndrome
    Hascoet, Sebastien
    Baruteau, Alban-Elouen
    Humbert, Marc
    Simonneau, Gerald
    Jais, Xavier
    Petit, Jerome
    Laux, Daniela
    Sitbon, Olivier
    Lambert, Virginie
    Capderou, Andre
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : 386 - 398
  • [34] Long Term Outcomes Of Pulmonary Arterial Hypertension In Patients Treated With Dasatinib
    Weatherald, J.
    Chaumais, M. -C.
    Savale, L.
    Jais, X.
    Seferian, A.
    Sitbon, O.
    Simonneau, G.
    Guignabert, C.
    Humbert, M.
    Montani, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [35] From short-term benefits to long-term outcomes: the evolution of clinical trials in pulmonary arterial hypertension
    Chakinala, Murali M.
    Barst, Robyn
    PULMONARY CIRCULATION, 2013, 3 (03) : 507 - 522
  • [36] Long-term Effects of Epoprostenol on the Pulmonary Vasculature in Idiopathic Pulmonary Arterial Hypertension
    Rich, Stuart
    Pogoriler, Jennifer
    Husain, Aliya N.
    Toth, Peter T.
    Gomberg-Maitland, Mardi
    Archer, Stephen L.
    CHEST, 2010, 138 (05) : 1234 - 1239
  • [37] The Role of Long-Term Daily Activity Monitoring for the Assessment of Functional Capacity in Pulmonary Arterial Hypertension
    Hughes, A.
    Annis, J.
    Hemnes, A.
    Lindsey, A.
    Burke, K.
    Horn, E.
    Brittain, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [38] The Role of Race in Pregnancy, Hypertension, and Long-Term Outcomes
    Levene, Jacqueline
    Chang, Alyssa
    Reddy, Anisha
    Hauspurg, Alisse
    Davis, Esa M.
    Countouris, Malamo
    CURRENT CARDIOLOGY REPORTS, 2025, 27 (01)
  • [39] Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS)
    Kolstad, Kathleen D.
    Li, Shufeng
    Steen, Virginia
    Chung, Lorinda
    CHEST, 2018, 154 (04) : 862 - 871
  • [40] Long-Term Outcomes in Idiopathic Pulmonary Arterial Hypertension (iPAH) Treated in the Netherlands, 1998-2007
    Jacobs, W.
    Brand, M.
    Rosenberg, D. M.
    Schaaf, B.
    Boonstra, A.
    Noordegraaf, A. Vonk
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
12345